Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Bayer, Bioinvent, Biontech, Brii, CASI, Cytodyn, Gan & Lee, Junshi, Moderna, Nrx, Pfizer, Roche.